keyboard_arrow_up

Global Histoplasmosis Clinical Trials Market Review H2 2014

“Histoplasmosis Global Clinical Trials Review, H2, 2014″ provides data on the Histoplasmosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Histoplasmosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Histoplasmosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

List of Tables

Histoplasmosis Therapeutics, Global, Clinical Trials by Region, 2014* 6

Histoplasmosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7

Histoplasmosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8

Histoplasmosis Therapeutics Clinical Trials, North America, Top Countries, 2014* 9

Proportion of Histoplasmosis to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 10

Histoplasmosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 11

Histoplasmosis Therapeutics, Global, Clinical Trials by Phase, 2014* 12

Histoplasmosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 13

Histoplasmosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 14

Histoplasmosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 15

Histoplasmosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 16

Histoplasmosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 17

Histoplasmosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 18

Histoplasmosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 19

Histoplasmosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 20

Histoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 21

Histoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014* 22

Histoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Pharmaceuticals, Inc., 2014* 23

Histoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Chemo Espana, S.A., 2014* 24

Histoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 25

Histoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2014* 26

Histoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2014* 27

Histoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Retina Research Institute of Texas, LLC, 2014* 28

Histoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Retina Associates of Kentucky, 2014* 29

Histoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Barnes Retina Institute, 2014* 30

To get Discount on this report, visit: http://www.rnrmarketresearch.com/contacts/discount?rname=256167 .

This is a premium report priced at US$2500 for a single user PDF.

Scope

·         Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

·         Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

·         Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

·         Understand the dynamics of a particular indication in a condensed manner

·         Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

·         Obtain discontinued trial listing for trials across the globe

·         Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies